FDA Warns on Expression; Lilly's Ixekizumab Data Promising
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Esther Freeman, MD, PhD
- DermWire TV
FDA Approves Rosacea Treatment Emrosi